शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
MANGALAMNSEMangalam Drugs And Organics Limited· Pharmaceuticals & BiotechnologyHighNegative
Announced Mon, 5 Jan, 2026 · 18:10 IST

Significant movement in price has been observed in Mangalam Drugs And Organics Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.

Regulatory & LegalExplain this filing

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+5.0%Reaction day
₹31.83
prior close
₹33.42
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.7%+5.7% vs market
Pharmaceuticals peers, median of 154sector-0.1%+5.1% vs sector

On the reaction day the stock moved 5.7 pts more than Nifty Microcap 250 and 5.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+5.0-0.7+5.7-0.1+5.1
Next day
+10.2-0.6+10.9+0.5+9.7
2d
+15.7-2.5+18.3-1.2+16.9
3d
+21.5-4.2+25.8-2.4+23.9
4d
+27.6-5.1+32.6-3.3+30.9
5d
+34.0-4.7+38.7-3.7+37.6
1w
+47.7-5.1+52.8-3.9+51.6
15d
+19.7-8.6+28.3-8.4+28.1
1m
+11.6-5.2+16.8-5.9+17.5
2m
+1.4-10.5+11.8-9.3+10.7
3m
-4.2-12.0+7.9-11.7+7.6
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NSE has observed an unusual and significant movement in the share price of Mangalam Drugs And Organics Limited. As a standard market safeguard, the exchange has written to the company asking for relevant information that could explain the price action. The company has not yet responded, and the exchange is awaiting its reply. Until the company clarifies, investors do not have an official reason for the price move. The stock will remain under the exchange's watch until a satisfactory response is received.

Likely market impact

This is a precautionary exchange query and not a penalty or adverse action. However, the lack of clarity may keep the stock volatile until the company responds. Investors should wait for the company's clarification before making decisions.